Literature DB >> 26446232

A National Survey to Systematically Identify Factors Associated With Oncologists' Attitudes Toward End-of-Life Discussions: What Determines Timing of End-of-Life Discussions?

Masanori Mori1, Chikako Shimizu2, Asao Ogawa3, Takuji Okusaka4, Saran Yoshida5, Tatsuya Morita6.   

Abstract

BACKGROUND: End-of-life discussions (EOLds) occur infrequently until cancer patients become terminally ill.
METHODS: To identify factors associated with the timing of EOLds, we conducted a nationwide survey of 864 medical oncologists. We surveyed the timing of EOLds held with advanced cancer patients regarding prognosis, hospice, site of death, and do-not-resuscitate (DNR) status; and we surveyed physicians' experience of EOLds, perceptions of a good death, and beliefs regarding these issues. Multivariate analyses identified determinants of early discussions.
RESULTS: Among 490 physicians (response rate: 57%), 165 (34%), 65 (14%), 47 (9.8%), and 20 (4.2%) would discuss prognosis, hospice, site of death, and DNR status, respectively, "now" (i.e., at diagnosis) with a hypothetical patient with newly diagnosed metastatic cancer. In multivariate analyses, determinants of discussing prognosis "now" included the physician perceiving greater importance of autonomy in experiencing a good death (odds ratio [OR]: 1.34; p = .014), less perceived difficulty estimating the prognosis (OR: 0.77; p = .012), and being a hematologist (OR: 1.68; p = .016). Determinants of discussing hospice "now" included the physician perceiving greater importance of life completion in experiencing a good death (OR: 1.58; p = .018), less discomfort talking about death (OR: 0.67; p = .002), and no responsibility as treating physician at end of life (OR: 1.94; p = .031). Determinants of discussing site of death "now" included the physician perceiving greater importance of life completion in experiencing a good death (OR: 1.83; p = .008) and less discomfort talking about death (OR: 0.74; p = .034). The determinant of discussing DNR status "now" was less discomfort talking about death (OR: 0.49; p = .003).
CONCLUSION: Reflection by oncologists on their own values regarding a good death, knowledge about validated prognostic measures, and learning skills to manage discomfort talking about death is helpful for oncologists to perform appropriate EOLds. IMPLICATIONS FOR PRACTICE: Oncologists' own perceptions about what is important for a "good death," perceived difficulty in estimating the prognosis, and discomfort in talking about death influence their attitudes toward end-of-life discussions. Reflection on their own values regarding a good death, knowledge about validated prognostic measures, and learning skills to manage discomfort talking about death are important for improving oncologists' skills in facilitating end-of-life discussions. ©AlphaMed Press.

Entities:  

Keywords:  Attitude; Do-not-resuscitate; End-of-life discussion; Hospice; Oncologist

Mesh:

Year:  2015        PMID: 26446232      PMCID: PMC4718424          DOI: 10.1634/theoncologist.2015-0147

Source DB:  PubMed          Journal:  Oncologist        ISSN: 1083-7159


  30 in total

1.  Physicians' ratings of their knowledge, attitudes, and end-of-life-care practices.

Authors:  Elizabeth H Bradley; Laura D Cramer; Sidney T Bogardus; Stanislav V Kasl; Rosemary Johnson-Hurzeler; Sarah M Horwitz
Journal:  Acad Med       Date:  2002-04       Impact factor: 6.893

Review 2.  Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care.

Authors:  Marco Maltoni; Augusto Caraceni; Cinzia Brunelli; Bert Broeckaert; Nicholas Christakis; Steffen Eychmueller; Paul Glare; Maria Nabal; Antonio Viganò; Philip Larkin; Franco De Conno; Geoffrey Hanks; Stein Kaasa
Journal:  J Clin Oncol       Date:  2005-09-01       Impact factor: 44.544

3.  Burnout syndrome in the practice of oncology: results of a random survey of 1,000 oncologists.

Authors:  D A Whippen; G P Canellos
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544

4.  The doctor's role in discussing advance preferences for end-of-life care: perceptions of physicians practicing in the VA.

Authors:  L Markson; J Clark; L Glantz; V Lamberton; D Kern; G Stollerman
Journal:  J Am Geriatr Soc       Date:  1997-04       Impact factor: 5.562

Review 5.  Communicating prognosis in cancer care: a systematic review of the literature.

Authors:  R G Hagerty; P N Butow; P M Ellis; S Dimitry; M H N Tattersall
Journal:  Ann Oncol       Date:  2005-06-06       Impact factor: 32.976

6.  Place of death: correlations with quality of life of patients with cancer and predictors of bereaved caregivers' mental health.

Authors:  Alexi A Wright; Nancy L Keating; Tracy A Balboni; Ursula A Matulonis; Susan D Block; Holly G Prigerson
Journal:  J Clin Oncol       Date:  2010-09-13       Impact factor: 44.544

7.  The influence of physician race, age, and gender on physician attitudes toward advance care directives and preferences for end-of-life decision-making.

Authors:  E W Mebane; R F Oman; L T Kroonen; M K Goldstein
Journal:  J Am Geriatr Soc       Date:  1999-05       Impact factor: 5.562

8.  Good death in cancer care: a nationwide quantitative study.

Authors:  M Miyashita; M Sanjo; T Morita; K Hirai; Y Uchitomi
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

9.  Can we talk? Inpatient discussions about advance directives in a community hospital. Attending physicians' attitudes, their inpatients' wishes, and reported experience.

Authors:  B M Reilly; C R Magnussen; J Ross; J Ash; L Papa; M Wagner
Journal:  Arch Intern Med       Date:  1994-10-24

10.  Associations between end-of-life discussions, patient mental health, medical care near death, and caregiver bereavement adjustment.

Authors:  Alexi A Wright; Baohui Zhang; Alaka Ray; Jennifer W Mack; Elizabeth Trice; Tracy Balboni; Susan L Mitchell; Vicki A Jackson; Susan D Block; Paul K Maciejewski; Holly G Prigerson
Journal:  JAMA       Date:  2008-10-08       Impact factor: 56.272

View more
  21 in total

1.  Nature of Discussions about Systemic Therapy Discontinuation or Hospice among Patients, Families, and Palliative Care Clinicians during Care for Incurable Cancer: A Qualitative Study.

Authors:  Lara Traeger; Chelsea Rapoport; Emily Wright; Areej El-Jawahri; Joseph A Greer; Elyse R Park; Vicki A Jackson; Jennifer S Temel
Journal:  J Palliat Med       Date:  2019-11-13       Impact factor: 2.947

2.  Transitions in Prognostic Awareness Among Terminally Ill Cancer Patients in Their Last 6 Months of Life Examined by Multi-State Markov Modeling.

Authors:  Chen Hsiu Chen; Fur-Hsing Wen; Ming-Mo Hou; Chia-Hsun Hsieh; Wen-Chi Chou; Jen-Shi Chen; Wen-Cheng Chang; Siew Tzuh Tang
Journal:  Oncologist       Date:  2017-07-06

3.  Adding a Wider Range and "Hope for the Best, and Prepare for the Worst" Statement: Preferences of Patients with Cancer for Prognostic Communication.

Authors:  Masanori Mori; Maiko Fujimori; Hiroto Ishiki; Tomohiro Nishi; Jun Hamano; Hiroyuki Otani; Yu Uneno; Akira Oba; Tatsuya Morita; Yosuke Uchitomi
Journal:  Oncologist       Date:  2019-02-19

4.  Accessibility, Availability, and Potential Benefits of Psycho-Oncology Services: The Perspective of Community-Based Physicians Providing Cancer Survivorship Care.

Authors:  Verena Zimmermann-Schlegel; Mechthild Hartmann; Halina Sklenarova; Wolfgang Herzog; Markus W Haun
Journal:  Oncologist       Date:  2017-04-24

5.  What determines the timing of discussions on forgoing anticancer treatment? A national survey of medical oncologists.

Authors:  Masanori Mori; Chikako Shimizu; Asao Ogawa; Takuji Okusaka; Saran Yoshida; Tatsuya Morita
Journal:  Support Care Cancer       Date:  2018-08-25       Impact factor: 3.603

6.  Barriers and facilitators in coping with patient death in clinical oncology.

Authors:  Leeat Granek; Samuel Ariad; Shahar Shapira; Gil Bar-Sela; Merav Ben-David
Journal:  Support Care Cancer       Date:  2016-05-05       Impact factor: 3.603

7.  Japanese physicians' attitudes toward end-of-life discussion with pediatric patients with cancer.

Authors:  Saran Yoshida; Chitose Ogawa; Ken Shimizu; Mariko Kobayashi; Hironobu Inoguchi; Yoshio Oshima; Chikako Dotani; Rika Nakahara; Masashi Kato
Journal:  Support Care Cancer       Date:  2018-05-17       Impact factor: 3.603

8.  Patient-physician discordance in goals of care for patients with advanced cancer.

Authors:  S L Douglas; B J Daly; N J Meropol; A R Lipson
Journal:  Curr Oncol       Date:  2019-12-01       Impact factor: 3.677

9.  Impact of Augmented Intelligence on Utilization of Palliative Care Services in a Real-World Oncology Setting.

Authors:  Ajeet Gajra; Marjorie E Zettler; Kelly A Miller; John G Frownfelter; John Showalter; Amy W Valley; Sanya Sharma; Shreenath Sridharan; Jonathan K Kish; Sibel Blau
Journal:  JCO Oncol Pract       Date:  2021-09-10

10.  Experience, Perceptions, and Recommendations Concerning COVID-19-Related Clinical Research Adjustments.

Authors:  David E Gerber; Thomas Y Sheffield; M Shaalan Beg; Erin L Williams; Valerie L Clark; Yang Xie; M E Blair Holbein; Celette Sugg Skinner; Simon J Craddock Lee
Journal:  J Natl Compr Canc Netw       Date:  2020-10-07       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.